26-Oct · 20-Oct
Nucleate is a global, volunteer-led 501(c)(3) nonprofit founded in 2018 at Harvard University, representing the largest student/trainee bio-innovator community worldwide. Its flagship Activator program empowers life science trainees (PhDs, MDs, MBAs, postdocs) to spin out ventures addressing human health (Bio Track) and planetary health (Eco Track: sustainability, food, energy, agriculture), bridging academia and industry through mutual-matching team formation, mentorship, legal and clinical consulting, and a Demo Day/Forum pitch. Activator runs in-person across 18 chapters spanning 40+ regions and 280+ academic institutions worldwide, plus a Global Virtual track for founders without a local chapter. No equity is taken, and IP from academic labs stays with the originating institution. Beyond Activator, Nucleate runs PATH (career development), Research, and Dojo, a subsidiary for undergraduate biotech talent. Its 2026 cohort selected 180 teams from 2,200+ applicants. Since founding, Activator has incorporated 303 companies, with alumni raising $650M+ and creating 1,000+ jobs. It ranked No. 54 on TIME and Statista’s 2026 list of America’s Best Incubators and Accelerators.
Frequency
1x/year
Duration
6 months
Investment
None — sponsor-funded perks and fellowships
Equity
None — equity-free program
Program fees
None
Where
Australia, Canada, Denmark, Germany, Israel, Switzerland, UK, USA, Virtual
Sectors
Biotech, Sustainability
Stages
Idea/Pre-Team, Pre-Seed
Eligibility
• Approval from the team’s Principal Investigator (PI) required
• Existing IP to protect the technology, or a clear path to file IP within the next year
• Open to projects with or without licensed IP (consent from tech transfer office required to participate)
• Team intending and willing to spin out as a company in the near future
• Less than one year to the next inflection point requiring substantial investment (translational academic or private)
Selection process
• “Mutual-matching” team formation phase pairing scientists, business trainees, and early professionals
• Workshops and mentor office hours
• Final pitch showcase (Demo Day / The Forum) before world-renowned judges
Benefits
• One-on-one direct feedback from top-tier life sciences experts across the biotech ecosystem
• Network-building with an exceptional cohort of executives, investors, scientists, and peers through exclusive Nucleate events
• Legal strategy guidance navigating IP and corporate law
• Clinical consulting — working with clinical residents to explore unmet clinical needs and interview key opinion leaders (KOLs)
• Private global seminars with top KOLs
• Demo Day / The Forum — pitch in front of program mentors, science entrepreneurs, industry veterans, and top-tier investors
Network
Platinum sponsors: Sigma-Aldrich, Eli Lilly, Alnylam, Genentech; Gold sponsors: BioMarin, Ipsen; Venture: Amino Collective; Legal: Fenwick; Banking + Spend: Mercury; Operational Accounting: Citrin Cooperman; Grant Writing: FedSprout; Ecosystem Partner: Teselagen; Philanthropic: Lyda Hill Philanthropies, Schmidt Futures; Operational Support: NTIP Law, Morrison & Foerster, Oxford Properties.
Portfolio
303 companies incorporated through Activator to date; 600+ teams enrolled across program history; 2026 cohort selected 180 teams from 2,200+ applicants across 400+ institutions, supported by 600 industry experts.
Funds raised
$650M+ raised to date by Activator portfolio companies; 1,000+ jobs created; 24 clinical-stage assets produced.
🕐 Sep 2026
Report an issue